We are live on
!
Find out more
Man Group Portfolio holdings
AUM
$62.7B
Turnover
25.36%
1-Year Est. Return
29.77%
This Fund
S&P 500
This Quarter
Est. Return
-1.99%
1 Year Est. Return
+29.77%
3 Year Est. Return
+99.46%
5 Year Est. Return
+125.78%
10 Year Est. Return
–
AUM
$55.1B
AUM Growth
-$3.71B
(-6.3%)
Cap. Flow
-$2.01B
Cap. Flow
% of AUM
-3.65%
Top 10 Holdings %
Top 10 Hldgs %
15.88%
Holding
2,628
New
414
Increased
1,064
Reduced
775
Closed
261
Avg Time Held Equity + Options
1.2
years
Top 10 Avg Time Held Equity + Options
1.5
years
Top 20 Avg Time Held Equity + Options
1
year
Avg Time Held Equity only
1.2
years
Top 10 Avg Time Held Equity only
1.5
years
Top 20 Avg Time Held Equity only
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HDFC Bank
HDB
|
+$185M |
| 2 |
PepsiCo
PEP
|
+$176M |
| 3 |
TE Connectivity
TEL
|
+$166M |
| 4 |
Ford
F
|
+$131M |
| 5 |
3M
MMM
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$418M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$352M |
| 3 |
Amazon
AMZN
|
+$296M |
| 4 |
NVIDIA
NVDA
|
+$237M |
| 5 |
Eaton
ETN
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.85% |
| 2 | Miscellaneous | 14.37% |
| 3 | Financials | 10.33% |
| 4 | Healthcare | 9.99% |
| 5 | Consumer Discretionary | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1701
Tigo Energy
TYGO
$63.3M
| $1.17M | ﹤0.01% |
311,661
+82,976
| +36% | +$275K |
2025 Q3
2 quarters
|
|
1702
Cactus
WHD
$4.3B
| $1.17M | ﹤0.01% |
+24,712
| New | +$1.3M |
2026 Q1
0 quarters
|
|
1703
Lineage Inc
LINE
$7.62B
| $1.17M | ﹤0.01% |
+35,592
| New | +$1.32M |
2026 Q1
0 quarters
|
|
1704
MannKind Corp
MNKD
$974M
| $1.16M | ﹤0.01% |
474,620
+296,126
| +166% | +$1.32M |
2023 Q4
9 quarters
|
|
1705
Castle Biosciences
CSTL
$979M
| $1.16M | ﹤0.01% |
47,138
+35,553
| +307% | +$1.16M |
2025 Q4
1 quarter
|
|
1706
Phreesia
PHR
$680M
| $1.15M | ﹤0.01% |
137,393
+93,727
| +215% | +$1.24M |
2025 Q4
1 quarter
|
|
1707
Array Digital Infrastructure
AD
$2.9B
| $1.15M | ﹤0.01% |
+24,860
| New | +$1.24M |
2026 Q1
0 quarters
|
|
1708
Sunstone Hotel Investors
SHO
$2.22B
| $1.15M | ﹤0.01% |
+127,231
| New | +$1.17M |
2026 Q1
0 quarters
|
|
1709
Paychex
PAYX
$39.2B
| $1.14M | ﹤0.01% |
12,421
+5,029
| +68% | +$498K |
2023 Q4
9 quarters
|
|
1710
OP Bancorp
OPBK
$222M
| $1.14M | ﹤0.01% |
85,928
+31,182
| +57% | +$429K |
2025 Q2
3 quarters
|
|
|
TWO
1711
DELISTED
Two Harbors Investment
TWO
| $1.14M | ﹤0.01% |
100,000
-82,503
| -45% | -$924K |
2025 Q4
1 quarter
|
|
1712
Core Scientific
CORZ
$4.39B
| $1.14M | ﹤0.01% |
76,283
-107,103
| -58% | -$1.83M |
2025 Q4
1 quarter
|
|
1713
Taboola.com
TBLA
$935M
| $1.14M | ﹤0.01% |
367,208
+20,548
| +6% | +$73.4K |
2025 Q3
2 quarters
|
|
1714
Bel Fuse Inc Class B
BELFB
$3.04B
| $1.13M | ﹤0.01% |
+5,709
| New | +$1.19M |
2026 Q1
0 quarters
|
|
1715
Xencor
XNCR
$1.7B
| $1.13M | ﹤0.01% |
93,694
+74,598
| +391% | +$926K |
2025 Q2
3 quarters
|
|
1716
American Integrity Insurance
AII
$538M
| $1.13M | ﹤0.01% |
58,535
+29,325
| +100% | +$559K |
2025 Q2
3 quarters
|
|
1717
Penguin Solutions Inc
PENG
$2.98B
| $1.13M | ﹤0.01% |
64,104
+36,152
| +129% | +$688K |
2025 Q2
3 quarters
|
|
1718
Ligand Pharmaceuticals
LGND
$5.85B
| $1.13M | ﹤0.01% |
5,644
+2,194
| +64% | +$434K |
2025 Q4
1 quarter
|
|
1719
RH
RH
$2.17B
| $1.12M | ﹤0.01% |
8,041
+1,399
| +21% | +$255K |
2025 Q2
3 quarters
|
|
1720
Relay Therapeutics
RLAY
$3.64B
| $1.12M | ﹤0.01% |
112,843
+25,806
| +30% | +$231K |
2024 Q4
5 quarters
|
|
1721
Vaxcyte
PCVX
$9.91B
| $1.12M | ﹤0.01% |
19,257
-49,656
| -72% | -$2.7M |
2024 Q3
6 quarters
|
|
1722
Artivion
AORT
$1.06B
| $1.12M | ﹤0.01% |
+30,473
| New | +$1.2M |
2026 Q1
0 quarters
|
|
1723
Digi International
DGII
$2.66B
| $1.11M | ﹤0.01% |
+23,096
| New | +$1.08M |
2026 Q1
0 quarters
|
|
1724
Kymera Therapeutics
KYMR
$8.74B
| $1.11M | ﹤0.01% |
13,334
-6,692
| -33% | -$530K |
2025 Q4
1 quarter
|
|
1725
N-able
NABL
$844M
| $1.11M | ﹤0.01% |
237,669
+101,174
| +74% | +$565K |
2025 Q4
1 quarter
|
|
Similar funds
Man Group's Q1 2026 Portfolio in Review
As of Q1 2026, Man Group held 2,628 positions worth $55.1B, down 6.3% from $58.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Man Group withdrew a net $2.01B in Q1 2026, closing 261 positions and reducing 775 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $418M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, Man Group opened a new position in AstraZeneca worth $122M.
- Man Group's largest Q1 2026 buy was AstraZeneca: 628,476 shares worth $122M.
- Man Group added most to HDFC Bank in Q1 2026, an estimated $185M increase.
- Man Group's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $352M.
- Man Group fully exited State Street SPDR S&P 500 ETF Trust in Q1 2026, selling an estimated $418M.
- Man Group's ten largest holdings make up 16% of its $55.1B portfolio in Q1 2026.
- Man Group opened 414 new positions and closed 261 in Q1 2026.
- Man Group's portfolio value fell 6.3% quarter-over-quarter to $55.1B.
Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.